Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

JLL Capital Markets announced on July 12 that it advised on the acquisition of a 53,120-square-foot medical office building (MOB) in Hamden, Connecticut. According to data captured in the LevinPro HC database, this represents the 120th MOB transaction of 2023 JLL represented Sendero Capital and Angelo Gordon, who have formed a programmatic joint venture (also arranged by JLL) for up to $300 million in investments in outpatient healthcare real estate over the next two years, in the acquisition. The purchase of the Hamden MOB is the first acquisition as part of the joint venture, which will focus on value-add and core plus outpatient medical office and surgery center assets throughout the... Read More »
PE-Backed Vantage Surgical Solutions Acquires Ophthalmic Surgical Solutions

PE-Backed Vantage Surgical Solutions Acquires Ophthalmic Surgical Solutions

Vantage Surgical Solutions, a portfolio company of private equity firm Pharos Capital Group, announced its acquisition of Ophthalmic Surgical Solutions (OSS). According to data captured in the LevinPro HC database, this transaction represents the 68th Medical Devices transaction of 2023. Founded in 2015, OSS is a Lecompton, Kansas-based company specializing in ophthalmic surgical equipment and services. Vantage Surgical Solutions is a leading provider of mobilized surgical solutions. Vantage has been equipping facilities for specialty surgical services since 1991, with customers in 23 states. The company currently delivers cataract surgery equipment, IOLs, instrumentation, disposables,... Read More »
Fortis Life Sciences Acquires International Point of Care

Fortis Life Sciences Acquires International Point of Care

Fortis Life Sciences, backed by Boston-based private equity firm Summit Partners, has acquired Toronto-based International Point of Care (IPOC). IPOC specializes in developing and manufacturing diagnostic components. IPOC serves many of the leading global diagnostic companies enabling the commercialization of new immunodiagnostic and molecular diagnostic technologies. Fortis Life Sciences partners with diagnostics and life sciences companies to custom-design, validate and manufacture proprietary solutions to solve their most difficult development problems. Fortis serves a global customer base and has offices worldwide including four R&D sites and three GMP and ISO 13485 compliant... Read More »
PurposeCare Acquires 3 Midwestern Home-Based Care Agencies

PurposeCare Acquires 3 Midwestern Home-Based Care Agencies

Chicago-based PurposeCare is expanding with the acquisition of three Midwestern home-based care agencies, Scott’s Home Healthcare and Attentive Personal Care, which are both located in Indiana, as well as Choice Nursing & Home Health in Ohio. Scott’s Home Healthcare is a family owned healthcare service provider for individuals and families in and around Kokomo, Indiana. The company specializes in Medicare skilled nursing in-home health services. Attentive Personal Care is an in-home care provider serving Indianapolis, Indiana and the surrounding area. Attentive Personal Care offers non-medical services in the home, such as meal preparation, housekeeping and transportation. Based in... Read More »
Kortesis Bharti Management Group Acquires Plastic Surgery of Texas

Kortesis Bharti Management Group Acquires Plastic Surgery of Texas

Kortesis Bharti Management Group, LLC announced on July 10 that it entered into an agreement to acquire Plastic Surgery of Texas.  Plastic Surgery of Texas provides plastic surgery services out of Dallas. It is run by one physician. Founded in 2021 by plastic surgeons, Dr. Bill Kortesis and Dr. Gaurav Bharti, Kortesis Bharti Management Group offers strategic growth and consulting services to practices and providers in the medical aesthetic space. It is an affiliate of H/K/B Cosmetic Surgery, PA. Plastic Surgery of Texas will be renamed Plastic Surgery of Texas by H/K/B. The financial terms of the acquisition were not disclosed. According to data captured in the LevinPro HC database,... Read More »
American Medical Administrators acquires Manzer Family Medicine

American Medical Administrators acquires Manzer Family Medicine

American Medical Administrators, Inc. (AMA) announced on July 10 that it acquired Manzer Family Medicine. Manzer Family Medicine is a family medicine practice in Kansas and Missouri. According to its website, the practice has two physicians on staff. AMA is a healthcare services company focused on providing greater access to healthcare for underserved communities across the United States. AMA offers walk-in urgent care services, combined with traditional family practice medicine and multi-specialty ambulatory surgical services. The financial terms were not disclosed. The deal expands AMA’s presence in Kansas and Missouri. Additionally, this follows AMA’s acquisition of Probst OB-GYN... Read More »
The US Oncology Network Acquires Cancer Center of Kansas

The US Oncology Network Acquires Cancer Center of Kansas

The US Oncology Network announced the addition of Cancer Center of Kansas (CCK) to its network, effective July 1, 2023, by entering into a new managed services partnership. Cancer Center of Kansas is one of largest physician-owned, independent oncology practices in Kansas. According to its website, the company has 13 physicians and six advanced practice providers, delivering care from 20 sites of service. Supported by McKesson Corporation, The US Oncology Network provides doctors with access to coordinated resources, best business practices and infrastructure. The company helps more than 1,400 independent physicians care for their patients. This addition expands The US Oncology Network’s... Read More »
Versiti Acquires Fishers, Indiana-based Quantigen

Versiti Acquires Fishers, Indiana-based Quantigen

Versiti has announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. The acquisition expands Versiti’s portfolio across the drug and medical device development pathway and adds complementary expertise supporting clinical trials in infectious disease, women’s health and gastrointestinal and reproductive health. Financial terms of the deal were not disclosed. Based in Fishers, Indiana, Quantigen is a contract research organization (CRO) and a patient diagnostic laboratory whose services are focused on supporting the development of novel diagnostic tests and medical devices. Versiti is a world-class blood health organization with locations across the... Read More »
Noteworthy Deals of The Second Quarter of 2023

Noteworthy Deals of The Second Quarter of 2023

With 586 transactions in the second quarter of 2023, we want to take a moment to look at several that are interesting, whether in purchase price or size of assets.  Merck & Co. Acquires Prometheus Biosciences  On April 17, Merck & Co announced that it acquired Prometheus Biosciences for $10.8 billion. Prometheus Biosciences is a clinical-stage biotechnology company that specializes in treating immune-mediated diseases. This acquisition represents the largest purchase price of the quarter, regardless of sector. Robert M. Davis, chairman and chief executive officer of Merck had this to say.  “The Prometheus acquisition accelerates our growing presence in immunology,... Read More »
Thermo Fisher Scientific to Acquire CorEvitas from Audax Private Equity

Thermo Fisher Scientific to Acquire CorEvitas from Audax Private Equity

Thermo Fisher Scientific Inc. announced that it entered into a definitive agreement to acquire CorEvitas, LLC from Audax Private Equity, for $912.5 million. The transaction is expected to be completed by the end of 2023. CorEvitas, based in Waltham, Massachusetts, with operations focused in the United States, provides regulatory-grade, real-world evidence solutions to pharmaceutical and biotechnology companies with objective data and clinical insights to improve patient care and clinical outcomes. CorEvitas manages 12 registries, including nine autoimmune and inflammatory syndicated registries. Its multi-therapeutic data intelligence platform builds and scales multiple clinical registries... Read More »